0001209191-21-023838.txt : 20210331 0001209191-21-023838.hdr.sgml : 20210331 20210331181758 ACCESSION NUMBER: 0001209191-21-023838 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210329 FILED AS OF DATE: 20210331 DATE AS OF CHANGE: 20210331 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HANLY ANN M. CENTRAL INDEX KEY: 0001854528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 21795133 MAIL ADDRESS: STREET 1: C/O VIR BIOTECHNOLOGY, INC. STREET 2: 499 ILLINOIS STREET, SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-29 0 0001706431 Vir Biotechnology, Inc. VIR 0001854528 HANLY ANN M. C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, SUITE 500 SAN FRANCISCO CA 94158 0 1 0 0 Chief Technology Officer Common Stock 2021-03-29 4 A 0 30000 0.00 A 30000 D Employee Stock Option (Right to Buy) 48.38 2021-03-29 4 A 0 60000 0.00 A 2031-03-28 Common Stock 60000 60000 D 1/4 of the shares subject to the stock option vest and become exercisable on March 29, 2022, and the remainder vest in 36 equal monthly installments thereafter. /s/ Howard Horn, Attorney-in-Fact 2021-03-31